Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: From preclinical evaluation to clinical validation

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chi, Chongwei ^a   Ye, Jinzuo ^a   Ding, Haolong ^b   He, De ^b   Huang, Wenhe ^b   Zhang, Guo Jun ^b   Tian, Jie ^a  

^a INSTITUTE OF AUTOMATION   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN;

ADULT; AGED; ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CAMERA; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; RABBIT; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURGICAL NAVIGATION SYSTEM; VIDEORECORDING;

ADULT; AGED; ANIMALS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT DYES; HUMANS; INDOCYANINE GREEN; LYMPH NODES; LYMPHATIC METASTASIS; MICE; MIDDLE AGED; NEOPLASM STAGING; RABBITS; SENTINEL LYMPH NODE BIOPSY;

EID: 84892646454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083927     Document Type: Article

References (41)

1. Denninghoff VC, Kahn AG, Falco J, Curutchet HP, Elsner B (2004) Sentinel lymph node: detection of micrometastases of melanoma in a molecular study. Mol Diagn 8: 253-258. doi: 10.2165/00066982-200408040-00007. PubMed: 15887981.
2. Mieog JSD, Troyan SL, Hutteman M, Donohoe KJ, Vorst JR et al. (2011) Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast. Cancer - Annals of Surgical Oncology 18: 2483-2491. doi:10.1245/s10434-011-1566-x.
3. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW et al. (2011) Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis: A Randomized. Clinical Trials - Archives of Surgery 146: 980-980.
4. Valsecchi ME, Silbermins D, de Rosa N, Wong SL, Lyman GH (2011) Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Melanoma: A Meta-Analysis. J Clin Oncol 29: 1479-1487. doi:10.1200/JCO.2010.33.1884. PubMed: 21383281.
5. Kootstra J, Hoekstra-Weebers JE, Rietman H, de Vries J, Baas P et al. (2008) Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol 15: 2533-2541. doi:10.1245/s10434-008-9996-9. PubMed: 18597146.
6. Hutteman M, Mieog JSD, Vorst JR, Liefers GJ, Putter H et al. (2011) Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat 127: 163-170. doi:10.1007/s10549-011-1419-0. PubMed: 21360075.
7. Hirche C, Murawa D, Mohr Z, Kneif S, Hünerbein M (2010) ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 121: 373-378. doi:10.1007/s10549-010-0760-z. PubMed: 20140704.
8. Sugie T, Sawada T, Tagaya N, Kinoshita T, Yamagami K et al. (2013) Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol 20: 2213-2218. doi:10.1245/s10434-013-2890-0. PubMed: 23429938.
9. Motomura K, Inaji H, Komoike Y, Kasugai T, Noguchi S et al. (1999) Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol 29: 604-607. doi:10.1093/jjco/29.12.604. PubMed: 10721942.
10. Motomura K, Inaji H, Komoike Y, Hasegawa Y, Kasugai T et al. (2001) Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol 76: 95-99. doi: 10.1002/1096-9098(200102)76:2. PubMed: 11223834.
11. Kitai T, Inomoto T, Miwa M, Shikayama T (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12: 211-215. doi:10.2325/jbcs.12.211. PubMed: 16110291.
12. Tagaya N, Yamazaki R, Nakagawa A, Abe A, Hamada K et al. (2008) Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 195: 850-853. doi:10.1016/j.amjsurg.2007.02.032. PubMed: 18353274.
13. Sugie T, Kassim KA, Takeuchi M, Hashimoto T, Yamagami K et al. (2010) A novel method for sentinel lymph node biopsy by indocyanine green fluorescence technique in breast cancer. Cancers (Basel) 2: 713-720. doi:10.3390/ cancers2020713. PubMed: 24281090.
14. Ogawa Y, Ikeda K, Ogisawa K, Tokunaga S, Fukushima H et al. (2013) Outcome of sentinel lymph node biopsy in breast cancer using dye alone: a single center review with a median follow-up of 5 years. Surg Today.
15. Yamamoto S, Maeda N, Yoshimura K, Oka M (2013) Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonography-guided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography. Breast, 22: 933-7. PubMed: 23726129.
16. Schaafsma BE, Verbeek FPR, Rietbergen DDD, van der Hiel B, van der Vorst JR et al. (2013) Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg 100: 1037-1044. doi:10.1002/bjs.9159. PubMed: 23696463.
17. Matsui A, Winer JH, Laurence RG, Frangioni JV (2011) Predicting the survival of experimental ischaemic small bowel using intraoperative near-infrared fluorescence angiography. Br J Surg 98: 1725-1734. doi: 10.1002/bjs.7698. PubMed: 21953541.
18. Sevick-Muraca EM (2012) Translation of Near-Infrared Fluorescence Imaging Technologies: Emerging Clinical Applications. Annual Review of Medicine, Vol 63 63: 217-231.
19. Gioux S, Choi HS, Frangioni JV (2010) Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging 9: 237-255. PubMed: 20868625.
20. Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV (2013) Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 10: 507-518. doi:10.1038/nrclinonc.2013.123. PubMed: 23881033.
21. Alford R, Simpson HM, Duberman J, Hill GC, Ogawa M et al. (2009) Toxicity of Organic Fluorophores Used in Molecular Imaging: Literature Review. Mol Imaging 8: 341-354. PubMed: 20003892.
22. Gilmore DM, Khullar OV, Gioux S, Stockdale A, Frangioni JV et al. (2013) Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann Surg Oncol 20: 2357-2363. doi:10.1245/s10434-013-2905-x. PubMed: 23440551.
23. Su Z, Ye P, Teng Y, Zhang L, Shu X (2012) Adverse reaction in patients with drug allergy history after simultaneous intravenous fundus fluorescein angiography and indocyanine green angiography. J Ocul Pharmacol Ther 28: 410-413. doi:10.1089/jop.2011.0221. PubMed: 22372690.
24. Themelis G, Yoo JS, Soh K-S, Schulz R, Ntziachristos V (2009) Real-time intraoperative fluorescence imaging system using light-absorption correction. J Biomed Opt 14: 064012. doi:10.1117/1.3259362. PubMed: 20059250.
25. Gibbs-Strauss SL, Rosenberg M, Clough BL, Troyan SL, Frangioni JV (2009) First-in-human clinical trials of imaging devices: an example from optical imaging. Conf Proc IEEE Eng Med Biol Soc 2009: 2001-2004. PubMed: 19964033.
26. Hutteman M, Choi HS, Mieog JS, van der Vorst JR, Ashitate Y et al. (2011) Clinical translation of ex vivo sentinel lymph node mapping for colorectal cancer using invisible near-infrared fluorescence light. Ann Surg Oncol 18: 1006-1014. doi:10.1245/s10434-010-1426-0. PubMed: 21080086.
27. Lee BT, Hutteman M, Gioux S, Stockdale A, Lin SJ et al. (2010) The FLARE Intraoperative Near-Infrared Fluorescence Imaging System: A First-in-Human Clinical Trial in Perforator Flap Breast Reconstruction. Plast Reconstr Surg 126: 1472-1481. doi:10.1097/PRS.0b013e3181f059c7. PubMed: 21042103.
28. Crane LMA, Themelis G, Arts HJG, Buddingh KT, Brouwers AH et al. (2011) Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: First clinical results. Gynecol Oncol 120: 291-295. doi:10.1016/j.ygyno.2010.10.009. PubMed: 21056907.
29. Pleijhuis RG, Langhout GC, Helfrich W, Themelis G, Sarantopoulos A et al. (2011) Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: Assessing intraoperative techniques in tissue-simulating breast phantoms. Eur J Surg Oncol 37: 32-39. doi:10.1016/j.ejso.2011.03.127. PubMed: 21106329.
30. Imai K, Minamiya Y, Saito H, Nakagawa T, Ito M et al. (2013) Detection of pleural lymph flow using indocyanine green fluorescence imaging in non-small cell lung cancer surgery: a preliminary study. Surg Today 43: 249-254. doi:10.1007/s00595-012-0237-2. PubMed: 22729459.
31. van Dam GM, Themelis G, Crane LMA, Harlaar NJ, Pleijhuis RG et al. (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med 17: 1315-1319. doi:10.1038/nm.2472. PubMed: 21926976.
32. Liu Y, Njuguna R, Matthews T, Akers WJ, Sudlow GP et al. (2013) Near-infrared fluorescence goggle system with complementary metal-oxide- semiconductor imaging sensor and see-through display. J Biomed Opt 18: 101303-101303. doi:10.1117/1.JBO.18.10.101303. PubMed: 23728180.
33. Goyal A, Newcombe RG, Chhabra A, Mansel RE (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase. Breast Cancer Res Treat 99: 203-208. doi:10.1007/s10549-006-9192-1. PubMed: 16541308.
34. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L et al. (2008) A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247: 207-213. doi:10.1097/SLA.0b013e31812e6a73. PubMed: 18216523.
35. Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE et al. (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol 17: 1854-1861. doi:10.1245/s10434-010- 0945-z. PubMed: 20300966.
36. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP et al. (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11: 927-933. doi:10.1016/S1470-2045(10)70207-2. PubMed: 20863759.
37. van der Vorst JR, Schaafsma BE, Verbeek FP, Hutteman M, Mieog JS et al. (2012) Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol 19: 4104-4111. doi:10.1245/s10434-012-2466-4. PubMed: 22752379.
38. Schaafsma BE, Verbeek FP, Rietbergen DD, van der Hiel B, van der Vorst JR et al. (2013) Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg 100: 1037-1044. doi:10.1002/bjs.9159. PubMed: 23696463.
39. Crane LM, Themelis G, Pleijhuis RG, Harlaar NJ, Sarantopoulos A et al. (2011) Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol 13: 1043-1049. doi:10.1007/s11307-010-0425-7. PubMed: 20835767.
40. Nguyen QT, Olson ES, Aguilera TA, Jiang T, Scadeng M et al. (2010) Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci U S A 107: 4317-4322. doi:10.1073/pnas.0910261107. PubMed: 20160097.
41. Savariar EN, Felsen CN, Nashi N, Jiang T, Ellies LG et al. (2013) Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides. Cancer Res 73: 855-864. doi:10.1158/0008-5472.CAN-12-2969. PubMed: 23188503.